Tag Archives: CENX

Top 10 Medical Stocks To Invest In 2019

Verrica Pharmaceuticals has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company expects to price its 5.0 million shares in the range of $14 to $16 a piece, with an overallotment option for an additional 750,000 shares. At the maximum price, the entire offering is valued up to $92.0 million. The company intends to list its shares on the Nasdaq under the symbol VRCA.

The underwriters for the offering are Merrill Lynch, Jefferies and Cowen.

This is a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.

Its lead product candidate, VP-102, is a proprietary drug-device combination of its novel topical solution of cantharidin, a widely recognized, naturally sourced agent to treat topical dermatological conditions, administered through a single-use precision applicator.

Top 10 Medical Stocks To Invest In 2019: International Tower Hill Mines Ltd(THM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    International Tower Hill Mines Ltd (NYSEAMERICAN:THM) (TSE:ITH) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 689,433 shares, a growth of 3.8% from the April 30th total of 663,894 shares. Based on an average daily volume of 155,359 shares, the short-interest ratio is currently 4.4 days. Approximately 0.5% of the shares of the company are short sold.

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.

Top 10 Medical Stocks To Invest In 2019: Approach Resources Inc.(AREX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Approach Resources (AREX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Century Aluminum (NASDAQ:CENX) was downgraded by research analysts at TheStreet from a “b-” rating to a “c” rating in a report released on Thursday.

  • [By Jon C. Ogg]

    Century Aluminum Co. (NASDAQ: CENX) was last seen up 16 cents at $14.97, but its 52-week range is $12.94 to $24.77. Its shares have a consensus analyst target of $22.80, and this traded at nearly $18 at the start of June.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Century Aluminum (CENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Earlier this month,the price of aluminum spiked after the U.S. government slapped sanctions on Rusal, the second-largest supplier of aluminum to the U.S. and Canada. That news sent the stocks of U.S. aluminum producers like Alcoa and Century Aluminum (NASDAQ:CENX) soaring on the belief that they’d profit from the higher prices that would likely result from the sanctions.

  • [By D.R. Barton, Jr.]

    According to industry leaders, including Century Aluminum Co. (Nasdaq: CENX) CEO Michael Bless, many of those jobs will be in jeopardy with the new taxes. And then there’s the reciprocal tariff reactions from other nations that would definitely hit the billions of dollars’ worth of U.S. agricultural exports with further jobs in jeopardy.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Fluor Corporation (NYSE: FLR) fell 13.4 percent to $51.10 in pre-market trading after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 9.8 percent to $28.97 in pre-market trading after surging 46.29 percent on Thursday.
    Gogo Inc. (NASDAQ: GOGO) shares fell 8.2 percent to $8.81 in pre-market trading after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 7.5 percent to $3.98 in pre-market trading after climbing 22.16 percent on Thursday.
    Arista Networks, Inc. (NYSE: ANET) fell 7.4 percent to $248.00 in pre-market trading following first-quarter earnings.
    Web.com Group, Inc. (NASDAQ: WEB) fell 6.7 percent to $18.00 in pre-market trading after reporting Q1 results.
    Varex Imaging Corporation (NASDAQ: VREX) fell 5.2 percent to $34 in pre-market trading after reporting Q2 results.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) shares fell 5.2 percent to $7.60 in pre-market trading after dropping 3.02 percent on Thursday.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 4.7 percent to $61.70 in pre-market trading following Q1 earnings.
    HSBC Holdings plc (NYSE: HSEA) fell 4.6 percent to $25.15 in pre-market trading after reporting Q1 results.
    Stratasys Ltd. (NASDAQ: SSYS) shares fell 4 percent to $16.66 in pre-market trading after dropping 2.86 percent on Thursday.
    Melco Resorts & Entertainment Limited (NASDAQ: MLCO) fell 4 percent to $30.65 in pre-market trading.
    Century Aluminum Co (NASDAQ: CENX) fell 4 percent to $15.76 in pre-market trading following Q1 results.
    HSBC Holdings plc (NYSE: HSBC) shares fell 3.5 percent to $48.10 in pre-market tr

Top 10 Medical Stocks To Invest In 2019: Arcadia Biosciences, Inc.(RKDA)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Chris Lange]

    Arcadia Biosciences, Inc. (NASDAQ: RKDA) watched its shares absolutely explode on Wednesday after the firm announced that it reached a couple key milestones. Specifically, the firm said that it achieved two technology milestones in its High Fiber Resistant Starch (RS) Wheat program.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Arcadia Biosciences (NASDAQ:RKDA) from a strong sell rating to a sell rating in a research note released on Friday.

    RKDA has been the topic of several other research reports. Piper Jaffray Companies set a $20.00 price target on Arcadia Biosciences and gave the company a hold rating in a report on Wednesday, March 14th. HC Wainwright initiated coverage on Arcadia Biosciences in a report on Tuesday, June 19th. They set a buy rating and a $20.00 price target on the stock.

  • [By Max Byerly]

    Arcadia Biosciences (NASDAQ: RKDA) and CVR Partners (NYSE:UAN) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

Top 10 Medical Stocks To Invest In 2019: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    The Children’s Place (NASDAQ: PLCE) and Stage Stores (NYSE:SSI) are both retail/wholesale companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.Stonemor Partners LP (STON) – 6,650,613 shares, 68.21% of the total portfolio. Shares added by 8.91%Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 21.11% of the total portfolio. Stage Stores Inc (SSI) – 1,750,000 shares, 6.3% of the total portfolio. Shares added by 75.00%Five Star Senior Living Inc (FVE) – 2,039,878 shares, 4.38% of the total portfolio. Added

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

  • [By Lisa Levin] Companies Reporting Before The Bell
    Best Buy Co., Inc. (NYSE: BBY) is projected to report quarterly earnings at $0.74 per share on revenue of $8.73 billion.
    McKesson Corporation (NYSE: MCK) is expected to report quarterly earnings at $3.56 per share on revenue of $51.25 billion.
    Medtronic plc (NYSE: MDT) is estimated to report quarterly earnings at $1.39 per share on revenue of $8.00 billion.
    Hormel Foods Corporation (NYSE: HRL) is projected to report quarterly earnings at $0.45 per share on revenue of $2.39 billion.
    Brady Corporation (NYSE: BRC) is expected to report quarterly earnings at $0.49 per share on revenue of $291.47 million.
    Sanderson Farms, Inc. (NASDAQ: SAFM) is projected to report quarterly earnings at $2.2 per share on revenue of $841.75 million.
    The Toronto-Dominion Bank (NYSE: TD) is estimated to report quarterly earnings at $1.16 per share on revenue of $6.86 billion.
    Royal Bank of Canada (NYSE: RY) is expected to report quarterly earnings at $1.61 per share on revenue of $8.05 billion.
    58.com Inc. (NYSE: WUBA) is projected to report quarterly earnings at $0.21 per share on revenue of $372.49 million.
    Luxoft Holding, Inc. (NYSE: LXFT) is estimated to report quarterly earnings at $0.59 per share on revenue of $228.53 million.
    The Toro Company (NYSE: TTC) is expected to report quarterly earnings at $1.21 per share on revenue of $916.73 million.
    StealthGas Inc. (NASDAQ: GASS) is projected to report quarterly earnings at $0.06 per share on revenue of $37.75 million.
    Stage Stores, Inc. (NYSE: SSI) is estimated to report earnings for its first quarter.
    Thermon Group Holdings, Inc. (NYSE: THR) is projected to report quarterly earnings at $0.2 per share on revenue of $96.24 million.
    Tuniu Corporation (NASDAQ: TOUR) is estimated to report quarterly loss at $0.03 per share on revenue of $76.72 million.

     

Top 10 Medical Stocks To Invest In 2019: Prudential Financial Inc.(PRU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    State of Tennessee Treasury Department lessened its position in Prudential Financial Inc (NYSE:PRU) by 29.7% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 312,450 shares of the financial services provider’s stock after selling 132,238 shares during the period. State of Tennessee Treasury Department owned approximately 0.07% of Prudential Financial worth $32,354,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Symphony Asset Management LLC lowered its position in Prudential Financial Inc (NYSE:PRU) by 18.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 16,149 shares of the financial services provider’s stock after selling 3,765 shares during the period. Symphony Asset Management LLC’s holdings in Prudential Financial were worth $1,672,000 as of its most recent SEC filing.

  • [By Chuck Saletta]

    Prudential Financial (NYSE:PRU) takes such pride in its rock-solid financial condition that it uses an actual rock — the Rock of Gibraltar– as its corporate symbol. Prudential Financial backs up that claim with a balance sheet that has more cash, cash equivalents, and short-term investmentsthan total debt on it. It also claims a debt-to-equity ratio around 0.6 and a current ratio around 1.0, which are further signs of a solid financial condition.

  • [By Max Byerly]

    Flippin Bruce & Porter Inc. grew its holdings in shares of Prudential Financial (NYSE:PRU) by 2.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 61,363 shares of the financial services provider’s stock after acquiring an additional 1,391 shares during the period. Flippin Bruce & Porter Inc.’s holdings in Prudential Financial were worth $6,354,000 as of its most recent SEC filing.

Top 10 Medical Stocks To Invest In 2019: Applied DNA Sciences Inc(APDN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends.

  • [By Logan Wallace]

    NV5 Global (NASDAQ: NVEE) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

  • [By Shane Hupp]

    Ascent Capital Group (NASDAQ: ASCMA) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

  • [By Max Byerly]

    These are some of the media headlines that may have effected Accern Sentiment’s rankings:

    Get Applied DNA Sciences alerts:

    Applied DNA Sciences’ (APDN) CEO James Hayward on Q2 2018 Results – Earnings Call Transcript (seekingalpha.com) Edited Transcript of APDN earnings conference call or presentation 3-May-18 8:30pm GMT (finance.yahoo.com) Applied DNA Sciences: Fiscal 2Q Earnings Snapshot (finance.yahoo.com) Applied DNA Sciences (APDN) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Applied DNA Reports Fiscal Second Quarter 2018 Financial Results (finance.yahoo.com)

    A number of research analysts have issued reports on the stock. Maxim Group set a $5.00 price target on shares of Applied DNA Sciences and gave the stock a “buy” rating in a report on Friday, April 6th. ValuEngine raised shares of Applied DNA Sciences from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

Top 10 Medical Stocks To Invest In 2019: Gogo Inc.(GOGO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Gogo Inflight Internet (NASDAQ:GOGO) was downgraded by research analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued on Friday.

  • [By ]

    Gogo Inc (Nasdaq: GOGO) reported record quarterly results in February with revenue up 18% over last year’s fourth quarter. The company missed high expectations for earnings, sending shares tumbling towards a 52-week low. Short sellers have piled on selling 53% of shares available and pushing the cover ratio up to 16 days.

  • [By Stephan Byrd]

    Gogo Inflight Internet (NASDAQ:GOGO) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totalling 36,604,500 shares, an increase of 11.5% from the April 30th total of 32,815,192 shares. Currently, 65.4% of the company’s shares are sold short. Based on an average trading volume of 3,480,011 shares, the short-interest ratio is currently 10.5 days.

  • [By Max Byerly]

    Gogo (NASDAQ:GOGO) last issued its earnings results on Friday, May 4th. The technology company reported ($0.34) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.58) by $0.24. The firm had revenue of $231.83 million during the quarter, compared to analyst estimates of $221.48 million. The firm’s revenue was up 40.2% compared to the same quarter last year. During the same period last year, the business earned ($0.52) EPS. analysts predict that Gogo Inc will post -2.21 earnings per share for the current fiscal year.

  • [By Joseph Griffin]

    Global Eagle Entertainment (NASDAQ: ENT) and Gogo Inflight Internet (NASDAQ:GOGO) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

Top 10 Medical Stocks To Invest In 2019: Houston Wire & Cable Company(HWCC)

Advisors’ Opinion:

  • [By Max Byerly]

    Houston Wire & Cable (NASDAQ:HWCC) hit a new 52-week high and low during mid-day trading on Wednesday after an insider bought additional shares in the company. The stock traded as low as $8.40 and last traded at $8.35, with a volume of 604 shares traded. The stock had previously closed at $7.90.

Top 10 Medical Stocks To Invest In 2019: Valley National Bancorp(VLY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Valley National Bank (NYSE:VLY) announced a quarterly dividend on Tuesday, May 22nd, RTT News reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.11 per share by the financial services provider on Tuesday, July 3rd. This represents a $0.44 annualized dividend and a dividend yield of 3.39%.

  • [By Joseph Griffin]

    Trustmark (NASDAQ: TRMK) and Valley National Bank (NYSE:VLY) are both mid-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.

  • [By Stephan Byrd]

    Federated Investors Inc. PA lessened its holdings in Valley National Bank (NYSE:VLY) by 12.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 352,694 shares of the financial services provider’s stock after selling 49,476 shares during the period. Federated Investors Inc. PA owned about 0.11% of Valley National Bank worth $4,395,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Swiss National Bank lifted its position in Valley National Bank (NYSE:VLY) by 21.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 544,300 shares of the financial services provider’s stock after purchasing an additional 94,600 shares during the period. Swiss National Bank owned about 0.16% of Valley National Bank worth $6,782,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Top Heal Care Stocks To Watch For 2018

Going into 2016, this popular composite indicator had a 65%-74% accuracy rate. It bombed in 2016. Should investors ignore or explore it for 2017?

This indicator is made up of three components: the Santa Claus rally (SCR), performance the first five trading days of January (F5D), and the January barometer (JB). Invented and popularized by the Stock Trader’s Almanac, the indicators basically act as barometer (as the indicator goes, the goes the following year).

Top Heal Care Stocks To Watch For 2018: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Alexander Bird]

    Aluminum producer Century Aluminum Co. (Nasdaq: CENX) added 3.3%to its share price, and Alcoa Corp. (NYSE: AA) edged up 0.2%, both closing out the day with gains.

  • [By D.R. Barton, Jr.]

    According to industry leaders, including Century Aluminum Co. (Nasdaq: CENX) CEO Michael Bless, many of those jobs will be in jeopardy with the new taxes. And then there’s the reciprocal tariff reactions from other nations that would definitely hit the billions of dollars’ worth of U.S. agricultural exports with further jobs in jeopardy.

  • [By ]

    You can see why Century Aluminum (Nasdaq: CENX) commended the President for “acting swiftly and boldly to save the American aluminum industry.” The company intends to ramp up operations at its smelter in Hawesville, Kentucky, putting 300 people back to work. In Illinois, US Steel (NYSE: X) is restarting a blast furnace that will employ at least 500 new workers.

Top Heal Care Stocks To Watch For 2018: Safeway Inc.(SWY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at:

  • [By Peter Graham]

    A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:

Top Heal Care Stocks To Watch For 2018: Winnebago Industries Inc.(WGO)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap motor home or RV stock Winnebago Industries (NYSE: WGO) reported fiscal Q4 2017 earnings before the market opened in Thursday with shares up in premarket trading on better than expected results and on a stock buyback program. Revenues for the fiscal Q4 ended August 26, 2017 increased72.8% to $454.9 million asrevenues for the Motorized segmentfell 4.4% to$226.2 million while revenues for the Towable segment rose $202.1 million to$228.7 million (driven by the addition of $193.4 million in revenue from the Grand Design acquisition and continued strong organic growth in Winnebago-branded Towable products, which increased 33% compared to last year).Q4 net incomeincreased 89.6% to$24.9 million.

  • [By ]

    Cramer was bearish on Grubhub (GRUB) , Sprint (S) , LG Homes (LGIH) , Acadia Pharmaceuticals (ACAD) , Pilgrim’s Pride (PPC) , Opko Health (OPK) , Alaska Air Group (ALK) and Winnebago Industries (WGO) .

  • [By Peter Graham]

    Small cap motor home or RV stock Winnebago Industries (NYSE: WGO) reported fiscal Q1 2018 earnings before the market opened on Wednesday with results easily topping forecastswith the Companypredicting a ninth straight year of growth for the industry. Revenues increased 83.5% to $450.0 million as revenues for the Motorized segmentfell 2.4% to$190.4 million while revenues for the Towable segment were $259.7 million for the quarter, up $209.5 million over the prior year, driven by the addition of $195.4 million in revenue from the Grand Design RV acquisition and continued strong organic growth in Winnebago-branded Towable products (which increased more than 50% compared to last year).Backlog remains strong while retail sales continue to outpace the industry for both brands.Net incomeincreased 53% to$17.958 million versus $11.738 million. The President/CEO commented:

  • [By Peter Graham]

    Small cap motor home or RV stock Winnebago Industries (NYSE: WGO) reported fiscal Q3 2017 earnings before the market opened this morning. Revenues increased 75.1% to $476.4 million as revenues for the Motorized segment fell 2% to$241.7 million and revenues for the Towable segment rose $209.3 million to $234.7 million driven by the addition of $196.9 million in revenue from the Grand Design acquisition (organic growth in Winnebago-branded Towable productswas up 49% compared to last year).Net income increased 34.3% to$19.4 million. The CEO commented:

  • [By Peter Graham]

    The Q2 2017 earnings report for small cap motor home or RV stock Winnebago Industries, Inc (NYSE: WGO) is scheduled for before the market opens onWednesday (March 22nd). Back in2014, Winnebago Industries was in our SmallCap Network Elite Opportunity (SCN EO) portfolioas we believed the company would benefit from lower gas pricesalong with aBaby Boomer generation whos recreational retirement spending will increase. OurSCN EO newsletter noting at the time:

Top Heal Care Stocks To Watch For 2018: MoSys, Inc.(MOSY)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    That’s why today we’ll show you one of our expert recommendations along with the 10 top-performing penny stocks to watch this week…

    Penny Stocks Current Share Price
    (as of Feb. 20) Feb. 12-20 Gain
    (as of Feb. 20)
    POET Technologies Inc. (OTCMKTS: POETF) $0.4165 85.1%
    Finjan Holdings Inc. (Nasdaq: FNJN) $2.94 67.05%
    Intelsat SA (NYSE: I) $3.50 38.89%
    Genesis Healthcare Inc. (NYSE: GEN) $1.39 37.62%
    Paringa Resources Ltd. (OTCMKTS: PNGZF) $0.41 32.30%
    CytoDyn Inc. (OTCMKTS: CYDY) $0.76 31.03%
    Iconix Brand Group Inc. (Nasdaq: ICON) $1.65 30.95%
    AMERI Holdings Inc. (Nasdaq: AMRH) $2.49 29.69%
    Pangea Logistics Solutions Ltd. (Nasdaq: PANL) $2.87 26.99%
    MoSys Inc. (Nasdaq: MOSY) $1.47 25.68%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Top Heal Care Stocks To Watch For 2018: SPDR Blmbg Barclays Intl Trs Bd ETF (BWX)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI also holds the SPDR Barclays Emerging Markets Local Bond ETF (NYSE: EBND), SPDR Barclays International Treasury Bond ETF (NYSE: BWX) and the SPDR Barclays Intermediate Term Corporate Bond ETF (NYSE: ITR).

best stock buys now

December 8, 2017: Here are four stocks trading with heavy volume among 73 equities making new 52-week lows in Friday’s session. On the NYSE advancers led decliners by about 3 to 2 and on the Nasdaq, advancers led decliners by about 8 to 7.

Sprint Corp. (NYSE: S) posted a new 52-week low of $5.42 Friday, down 0.7% after closing at $5.46 on Thursday. The 52-week high is $9.65. Volume was about 14.5 million, nearly 15% below the daily average of around 16.9 million shares. The company is expected to raise prices as competition cools. Investors aren’t sure they agree.

American Outdoor Brands Corp. (NASDAQ: AOBC) dropped about 16.5% Friday to post a new 52-week low of $12.46 after closing at $14.93 on Thursday. The 52-week high is $24.49. Volume was around 11.5 million, nearly 6 times the daily average of about 1.7 million. The maker of Smith & Wesson firearms beat quarterly estimates but cut its full-year forecasts sharply.

Veeco Instruments Inc. (NASDAQ: VECO) dropped nearly 26% Friday to post a new 52-week low of $10.85 after closing at $14.65 on Thursday. The 52-week high is $34.38. Volume was around 5.8 million, about 10 times the daily average of around 584,000. The company reported late yesterday that it had received an unfavorable patent ruling in China.

best stock buys now: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    McKesson Corp. (NYSE: MCK), the leading pharmaceutical distributor, posted a revenue increase in the past year of $49.7 billion, up from $47.5 billion in ayear earlier. Its management offered hefty earnings for the quarter and year ahead. It continues to be a buyer of other companies, most recently Change Healthcare (which was labeled a merger with one of McKesson’s divisions). The current dividend is $1.12, or 0.61%.

  • [By Dan Caplinger]

    Drug-distribution specialist McKesson (NYSE:MCK) has had a tough year. Even as the overall stock market has climbed, the company’s shares have suffered, as investors fear that any business related to pharmaceuticals will have a political target on its back even under the current administration. Last quarter’s sluggish numbers didn’t create much enthusiasm for McKesson either.

  • [By ]

    McKesson Corporation (NYSE: MCK) is the largest wholesale distributor of pharmaceuticals, counting CVS and Walmart as major customers. Along with rivals Cardinal Health and AmerisourceBergen, the three control 90% of the $300 billion retail pharmaceutical distribution market.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 1.77 percent. Meanwhile, top losers in the sector included McKesson Corporation (NYSE: MCK), down 24 percent, and Novo Nordisk A/S (ADR) (NYSE: NVO), down 13 percent.

best stock buys now: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

best stock buys now: Gaming and Leisure Properties, Inc.(GLPI)

Advisors’ Opinion:

  • [By Seth McNew]

    One way Penn has been able to unlock extra value is by spinning off a portion of operations as a real estate investment trust (REIT) as a way to split up the physical property from the gaming operations. Following that 2013 creation of Gaming and Leisure Properties Inc(NASDAQ:GLPI),Penn essentially pays leasing fees to the REIT so it can focus on operations with a leaner balance sheet. Here’s a more in-depth analysis of the upside of Penn’s REIT model.

  • [By Monica Gerson]

    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 3.25 percent to $31.90 in pre-market trading. Gaming and Leisure Properties priced offering of 10.53 million shares of common stock for gross proceeds of $333 million.

best stock buys now: Goldfield Corporation (The)(GV)

Advisors’ Opinion:

  • [By Jim Robertson]

    Just before Thanksgiving, our Under the Radar Moversnewsletter suggested buying small cap electrical infrastructure stockGoldfield Corp (NYSEMKT:GV):

best stock buys now: Westell Technologies, Inc.(WSTL)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap high-performance wireless infrastructure solutions stock Westell Technologies (NASDAQ: WSTL) as a buy for our short-term portfolio:

best stock buys now: Apogee Enterprises, Inc.(APOG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Let me introduce you to Apogee Enterprises (APOG) a company with “yuge” profit potential. Founded in 1949 and headquartered in Minneapolis, Minnesota, APOG designs and develops glass solutions for commercial buildings.

Top 10 Undervalued Stocks To Invest In Right Now

Over the past year, the performance of T. Rowe Price Blue Chip Growth (TRBCX has underscored why it pays to sit tight when a fund with a superior long-term record hits a speed bump. In 2016, as investors turned away from shares of the fast-growing, large-capitalization stocks that Blue Chip targets in favor of more-undervalued fare, the fund lagged the stock market dramatically. Stocks that had previously buoyed the fund, such as Amazon.com and Facebook, were suddenly a drag, says manager Larry Puglia. And energy and utility stockssectors that Blue Chip tends to ignoreperformed exceptionally well.

See Also: Kip 25 Best No-Load Mutual Funds 2017

But these kinds of style shifts dont last forever. Large-cap growth stocks, led by the technology sector, are rebounding this year, and Blue Chip is benefiting. In the first three months of 2017, the fund returned 10.4%, beating Standard & Poors 500-stock index by 4.3 percentage points. Over the past 12 months, Blue Chip, a member of the Kiplinger 25, outpaced the index by nearly a full percentage point. (Prices and returns are through March 31)

Top 10 Undervalued Stocks To Invest In Right Now: L-3 Communications Holdings, Inc.(LLL)

Advisors’ Opinion:

  • [By Paul Ausick]

    Five teams are expected to compete for the contract: Boeing Co. (NYSE: BA) has joined with Saab to offer a clean-sheet design; Northrop Grumman Corp. (NYSE: NOC) has teamed up with BAE Systems and L-3 Communications Holdings Inc. (NYSE: LLL) on another clean-sheet design; Lockheed Martin Corp. (NYSE: LMT) and Korea Aerospace Industries (KAI) are going with a modified KAI T-50; Raytheon Corp. (NYSE: RTN) has joined with Italy’s Leonardo and Canada’s CAE Inc. (NYSE: CAE) on a version of Leonardo’s M-346 trainer that it calls the T-100; and privately held Sierra Nevada has partnered with Turkish Aerospace Industries (TAI) on another clean-sheet design.

  • [By Peter Graham]

    A long term performance chart shows ViaSat, Inc plus mid to large cap communications stockslikeHarris Corporation (NYSE: HRS) and L-3 Communications Holdings, Inc (NYSE: LLL)had been moving in tandem until last yearwhile small cap Gogo Inc has underperformed:

  • [By Peter Graham]

    Headquartered in New York City, large cap L3 Technologies Inc (NYSE: LLL) employs approximately 38,000 people worldwide and is a leading provider of a broad range of communication, electronic and sensor systems used on military, homeland security and commercial platforms. L3 is also a prime contractor in aerospace systems, security and detection systems, and pilot training. The Company reported 2016 sales of $10.5 billion.

Top 10 Undervalued Stocks To Invest In Right Now: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Cloud-software leader Salesforce (CRM) – my Top Pick for 2017 among large cap technology stocks — remains well positioned to reap the benefits of the transition away from on-premises solutions.

  • [By WWW.THESTREET.COM]

    “There are two things that mess up your relationships, it’s anger and fear,” explains Robbins. Robbins points to Salesforce (CRM) CEO Marc Benioff as being a total giver, which has set him up for success in business.

  • [By Peter Graham]

    On the earnings call, Ellison noted that the company had surpassed Salesforce.com, inc (NYSE: CRM) in annualized recurring cloud revenue: We are now well on our way to passing them and becoming number one in the enterprise SaaS market.”

Top 10 Undervalued Stocks To Invest In Right Now: TG Therapeutics, Inc.(TGTX)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Treehouse Foods (THS) , TG Therapeutics (TGTX) , Kinder Morgan (KMI) , Magellan Midstream Partners (MMP) , Chesapeake Energy (CHK) and Arconic (ARNC) .

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

  • [By Brian Orelli]

    TG Therapeutics (NASDAQ:TGTX)rose 15% today, after an analyst at Jefferies initiated coverage with a buy and a $23 price target.

    So what

    Analyst action often has an effect on company’s stock price, especially in the short term, but today’s move may be exacerbated by an upcoming data release at the American Academy of Neurology meeting scheduled for Friday. Investors may have been jumping in today ahead of the binary event, hoping that Friday’s data will be positive enough to send the share price even higher.

Top 10 Undervalued Stocks To Invest In Right Now: TESARO, Inc.(TSRO)

Advisors’ Opinion:

  • [By Todd Campbell]

    Tesaro’s (NASDAQ:TSRO)ovarian cancer drug, niraparib, will begin competing for prescriptions earlier than expected. Niraparib, which will be sold under the brand name Zejula, notched FDA approval on Monday, more than three months ahead of its June 30 decision date. The early approval setsTesaro up for a fierce battle for market share withAstraZeneca (NYSE:AZN)and Clovis Oncology (NASDAQ:CLVS), both of which market drugs that work similarly to Zejula.

  • [By Ben Levisohn]

    Shares of Tesaro (TSRO) are soaring today after the biotech company reported positive data for its treatment of ovarian cancer over the weekend. Credit Suisse analyst Alethia Young and team contend that “M&A remains in focus” for Tesaro following the data:

    Getty Images

    We are increasing our target price to $122 from $90 as we move to an M&A DCF valuation. We were at ESMO this weekend, and we believe the big takeaway on Tesaro data is that it works broadly in all 2L ovarian populations and safety looks solid. We also think the robustness of this data bodes well from PRIMA and QUADRA but are maintaining our POS here. We have looked at our model and also adjusted durations in first-line. We think Tesaro remains one of the most attractive and de-risked cancer assets in our landscape and the company has been cited in major press sources as a takeout target (Bloomberg, Investor Business Daily).

    We think M&A remains in focus for Tesaro. Our M&A DCF valuations range from $122 to $157 by our model. We have also built models for other cancers like NSCLC, SCLC, prostate, and others where PARP might be impactful. We assume 0% POS for now but we conservatively see at least another $1B in sales from PARP expansion. Tesaro has been cited in the press as a potential M&A target and is a company we frequently hear mentioned as a target from our conversations. We think the demand for late stage oncology assets is high, especially in the PARP space given the potential for activity across a range of tumors. For a large Pharma player who already has an oncology salesforce and large R&D infrastructure we could see SG&A synergies of 50-75% and R&D synergies of 15-30%. In our base case TSRO P&L we model a tax rate of 30% so there could be synergies here as well. Two additional key swing factors which might be included in a CVR are how much expansion from PARP in other cancers and immuno-oncology…

    Ex M&A,

  • [By Ben Levisohn]

    Look out below! Shares of Tesaro (TSRO) have dropped more than 10% this afternoon after AstraZeneca (AZN) released stronger-than-expected Phase 3 trial data on a its ovarian cancer treatment.

    Agence France-Presse/Getty Images

    The Street’sAdam Feuerstein has the details on AstraZeneca’s strong data and its impact on Tesaro:

    AstraZeneca’s (AZN) PARP inhibitor Lynparza delayed the recurrence of ovarian cancer by more than two years compared to a placebo, according to results from a phase III study presented Tuesday.

    The strong benefit observed with Lynparza as ovarian cancer maintenance therapy exceeded investor expectations and bolsters AstraZeneca against a competing PARP inhibitor from Tesaro (TSRO).

    Feuerstein also notes that AstraZeneca’s data could be good newsClovis Oncology (CLVS), which also had a PARP inhibitor approved recently, if it means that its drug could work as well as Astra’s.

    In February, Leerink cut Tesaro, arguing that the rally in its shares due to a potential takeover had run too far. Will it still be a takeover target?

    Shares of Tesaro have dropped 14% to $148.01 at 3:28 p.m. today, while AstraZeneca has gained 1.1% to $30.41, and Clovis Oncology has jumped 9.8% to$66.55.

    UPDATE:Piper Jaffray’sSteven Breazzano andJoshua Schimmer note that the AstraZeneca data shows that PARPs are “more similar than different.” They explain:

    This afternoon AstraZeneca (covered by PJC analyst Richard Purkiss) reported the detailed results from the SOLO-2 maintenance study of Lynparza in 2L+ ovarian cancer. The detailed data highlights a PFS benefit of 14 months (investigator assessed, and primary endpoint) and 25 months (blinded central review) over placebo, and favorable hazard ratio of 0.30 and 0.25, respectively, confirming our view that the PARP’s are more similar than different. As such, we believe this provides a favorable readth

  • [By Ben Levisohn]

    Guggenheim’s Tony Butler and Kaitlin Sandor argue that Gilead Sciences (GILD) should buy Syndax Pharmaceuticals (SNDX), Corvus Pharmaceuticals (CRVS), and Tesaro (TSRO) to solve its problem of slowing sales:

  • [By George Budwell]

    Unfortunately for Clovis and its shareholders, though, Astra’s Lynparza is currently underpriority review with the FDA as a maintenance therapy in ovarian cancer, andTesaro’s (NASDAQ:TSRO)rival PARP inhibitor Zejula gained an early approval– along with afar broader label than Rubraca — just this week.

  • [By Todd Campbell]

    The PARP battle is on. Following news that AstraZeneca’s (NYSE:AZN) PARP-inhibiting cancer drug Lynparza delivered a big win in phase 3 studies, all eyes now shift to how a potential Food and Drug Administration approval for Lynparza will reshape the commercial opportunity for competitor Tesaro Inc. (NASDAQ:TSRO).

Top 10 Undervalued Stocks To Invest In Right Now: Intercontinental Exchange Inc.(ICE)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Altria (MO) , Intercontinental Exchange (ICE) and Micron Technology (MU) .

    Cramer was bearish on NVIDIA (NVDA) and Reynolds American (RAI) .

Top 10 Undervalued Stocks To Invest In Right Now: Exactech Inc.(EXAC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

Top 10 Undervalued Stocks To Invest In Right Now: Cemex S.A.B. de C.V.(CX)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Cemex SAB de CV (CX) is very interesting at these levels as it seems the market is pricing in a stronger dollar (thereby reducing revenue) and thus lower growth.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) dropped about 2.4% Friday to post a new 52-week low of $7.41 after closing at $7.59 on Thursday. The 52-week high is $10.37. Volume was around 8.8 million, about 15% below the daily average of around 9.3 million. The Mexico-based cement company had no specific news.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) dropped about 2.7% Thursday to post a new 52-week low of $7.57 after closing at $7.78 on Wednesday. The 52-week high is $10.37. Volume was around 6.8 million, about 15% below the daily average of around 8.3 million. The Mexico-based cement company had no specific news.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) dropped about 1.8% Wednesday to post a new 52-week low of $7.16 after closing at $7.29 on Tuesday. The 52-week high is $10.37. Volume was around 7 million, about 20% below the daily average of around 9.5. The Mexico-based cement company had no specific news.

Top 10 Undervalued Stocks To Invest In Right Now: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was indicated down 7% at $72.85 on Thursday due to results from a seizure medication study. It was downgraded to Neutral from Overweight at Piper Jaffray, and Wedbushlowered its target for the stock.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Johanna Bennett]

    Nothing guts a drug stock like bad clinical trial data. Shares of Ultragenyx Pharmaceutical (RARE) fell as much as 10% after a seizure medication failed in a phase II study.

    Trading at a recent $72.22, the shares were down 7.7% after earlier falling as much as 10% to $70.51

    The seizure drug UX007 was tested as a treatment for glucose transporter type-1 deficiency syndromeor Glut1 DSamong a small group of patients. Data released Wednesday showed that it only cut the rate of seizures in the drug arm by 13.4% compared to the placebo arm, falling short of statistical significance.

    Investigators, though, teased out a clinically — though not statistically — significant benefit for patients experiencing what are called absence seizures. Ultragenyx now intends to focus on that in a Phase III pivotal trial.

    Leerik analyst Joseph Schwartz called the selloff a buying opportunity.

    We had been cautious on this asset (and its two programs – G1DS and long-chain fatty acid oxidation disorder/LC-FAOD; LINK) – but believe the selling pressure after mkt. presents a buying opportunity ahead of a more de-risked X-linked hypophosphatemia (XLH) Ph.3 data in 1H17.

    Cowen analyst Eric Schmidt remained convinced of RAREs long-term prospects thanks to a diversified orphan disease pipeline. And analysts at Credit Suisse see more catalysts ahead in 2017.

    We are buyers on a pullback and we like RAREs setup for the remainder of 2017…Remaining 2017 catalysts keep us buyers on a pullback: We see Q2:17 KRN23 ph3 adult XLH data, H1:17 rhGUS FDA/EMA submission, potential KRN23 CHMP decision in mid-17 (based on late-2016 EMA submission/validation), H2:17 Ace-ER ph3 GNEM data, and potential KRN23 FDA submission in late-17/early-18 as upcoming catalysts worth owning for.

Top 10 Undervalued Stocks To Invest In Right Now: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

Top 10 Undervalued Stocks To Invest In Right Now: Lithium X Energy Corp. (LIXXF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

  • [By Tom Bishop]

    Lithium X Energy NPV (LIXXF) owns 50% of the Sal de los Angeles lithium brine project in the prolific “Lithium Triangle” in mining friendly Salta province, Argentina.

number one stock to buy

8 Things Most Americans Dont Know About Retirement

Comments Flood In on DOL Fiduciary Rule Delay

Betterment Rebuffs Buffett, Says Sages Advice Doesnt Work Anymore

In spite of the severe impact the financial crisis had, a slew of eager, bonus-hungry millennials are now working in the industry in hopes of forging successful careers. How are they doing?

Alas, many are a strung-out, rattled mess, Jonathan Alpert, known as “The Wall Street Therapist,” told ThinkAdvisor in an interview. The practitioner counts several young traders, analysts, bankers and financial advisors among his clients.

Do these Wall Streeters ever seek your services because of adverse effects from, for example, overuse of cocaine?

On occasion. If it’s affecting their relationships or their work performance.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

number one stock to buy: Murphy Oil Corporation(MUR)

Advisors’ Opinion:

  • [By Matt Egan]

    Before Tuesday, Big Oil’s credit ratings had been left largely intact by S&P. But with oil sinking back to $30 a barrel, the ratings firm took action by downgrading Chevron (CVX), EOG Resources (EOG), Apache (APA), Devon Energy (DVN), Hess (HES), Marathon Oil (MRO), Murphy Oil (MUR), Continental Resources (CLR) and Southwestern Energy (SWN).

  • [By Joshua Bondy]

    Murphy Oil (NYSE: MUR  ) has already spun off its US retail operations into Murphy Oil USAandis exploring the possibility of spinning off its U.K. refining operations. Divesting its refineries will help direct excess cash to developing new fields.

  • [By Ben Levisohn]

    It wasn’t just Marathon that got clipped as the eight worst-performing stocks in the S&P 500 came from the energy sector, including Murphy Oil (MUR), which fell 6.7% to $25.87, Devon Energy (DVN), which slid 6.5% to $40.72, and Chesapeake Energy (CHK), which stumbled 6.1% to $4.94. No surprise, then, that the Energy Select Sector SPDR ETF (XLE) slumped 2.6% to $69.65.

  • [By Ben Levisohn]

    Today, it was all about oil afterOPEC “reached an understanding” on capping oil production. And that made Murphy Oil (MUR) the hottest stock in the S&P 500.

number one stock to buy: Century Aluminum Company(CENX)

Advisors’ Opinion:

  • [By Craig Jones]

    JPMorgan’s analyst Michael Gambardella downgraded Century Aluminum Co (NASDAQ: CENX) from Overweight to Neutral and reduced its price target from $22 to $14.50, citing alumina cost headwinds as the main reason for the downgrade.

number one stock to buy: SPDR Dow Jones Industrial Average ETF (DIA)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    A good way to play this is by buying the SPDR Dow Jones Industrial Average ETF (DIA), which tracks the Dow Industrials. We add that the SPDR S&P 500 ETF Trust (SPY) would be a good bet as well.

  • [By Tom Gentile]

    An ETF is a fund that tracks indexes such as the Dow Jones Industrial Average and the S&P 500. ETFs basically let you trade an entire sector instead of having to pick and choose specific stocks to trade within a sector. ETFs are also a great way for you to hedge against rising interest rates. When it comes to equities, a good ETF to monitor is the SPDR Dow Jones Industrial Average ETF (NYSE Arca: DIA). For bonds, the iShares 20+ Year Treasury Bond ETF (NYSE Arca: TLT) is a good way to gauge the bullishness or bearishness of the overall bond market.

  • [By WWW.MONEYSHOW.COM]

    An easy way to profit from this bull market is to buy the ETFs that track these major averages – the SPDR Dow Jones Industrial Average ETF (DIA) and iShares Dow Jones Transportation Average ETF (IYT).

  • [By Elizabeth Balboa]

    Since the beginning of 2017, the NIFTY has outperformed both the SPDR S&P 500 ETF Trust (NYSE: SPY) and SPDR Dow Jones Industrial Average ETF (NYSE: DIA), with each seeing respective increases of 12.6 percent, 6 percent and 4.9 percent.

number one stock to buy: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Douglas A. McIntyre]

    McKesson Corp. (NYSE: MCK), the leading pharmaceutical distributor, posted a revenue increase in the past year of $49.7 billion, up from $47.5 billion in ayear earlier. Its management offered hefty earnings for the quarter and year ahead. It continues to be a buyer of other companies, most recently Change Healthcare (which was labeled a merger with one of McKesson’s divisions). The current dividend is $1.12, or 0.61%.

  • [By Ben Levisohn]

    Leerink’s David Larsen and Matt Dellelo traces today’s big gain to Amerisource’s big drop following McKesson’s (MCK) earnings last week:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 1.77 percent. Meanwhile, top losers in the sector included McKesson Corporation (NYSE: MCK), down 24 percent, and Novo Nordisk A/S (ADR) (NYSE: NVO), down 13 percent.

  • [By Dan Caplinger]

    Drug-distribution specialist McKesson (NYSE:MCK) has had a tough year. Even as the overall stock market has climbed, the company’s shares have suffered, as investors fear that any business related to pharmaceuticals will have a political target on its back even under the current administration. Last quarter’s sluggish numbers didn’t create much enthusiasm for McKesson either.

number one stock to buy: Rex Energy Corporation(REXX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Our peer group is up an average of 46% over the past 4 weeks in response to a 30% rebound in the 12-month strip NYMEX oil price. Some of the largest gainers include Hold and Sell rated stocks that we would not chase such asDenbury Resources (Sell, +138%), Halcon Resources (HK) (Sell, +147%), Jones Energy (JONE) (Hold, +166%), Rex Energy (REXX) (Sell, +60%), Sanchez Energy (SN) (Hold, +93%), Ultra Petroleum (UPL) (Sell, +61%), andWhiting Petroleum (Hold, +103%), which have outperformed the E&P Index (+32%) over the same time period. Balance sheets and/or well level returns remain challenged for these companies despite improved oil prices. While we believe oil markets should re-balance over the next 12 to 15 months, the recent recovery to $40 could reverse during 2Q16 as bloated inventories continue to rise, new volumes from Iran pressure an oversupplied market, and a highly anticipated decline in non-OPEC supply (especially in the U.S.), is not as steep as expected. The risk of an oil price retracement, which would significantly pressure the recent out-performers, outweighs the upside in these stocks, in our view. However, we are raising our target prices on Buy ratedAnadarko Petroleum ($54 from $48), Concho Resources (CXO) ($120 from $109), Matador Resources (MTDR) ($22 from $21),Noble Energy (NBL) ($40 from $34), SM Energy (SM) ($22 from $15), Rice Energy ($14 from $12), Pioneer Natural Resources (PXD) ($155 from $135),Continental Resources ($32 from $28), and Parsley Energy (PE) ($24 from $23). We believe our Buy-rated stocks are better positioned to weather challenging oil markets.

number one stock to buy: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of AmTrust Financial Services Inc (NASDAQ: AFSI) were down around 18 percent to $22.79 after the company posted downbeat Q4 earnings.

    Shutterstock Inc (NYSE: SSTK) was down, falling around 19 percent to $42.04 after the company reported downbeat Q4 results and issued a weak outlook.

  • [By Lisa Levin]

    In trading on Friday, financial shares fell 0.24 percent. Meanwhile, top losers in the sector included AmTrust Financial Services Inc (NASDAQ: AFSI), down 18 percent, and GSV Capital Corp (NASDAQ: GSVC), down 9 percent.

  • [By Dan Caplinger]

    The stock market kept performing well on Monday, and the Dow Jones Industrials posted its 12th straight all-time record high. Market sentiment was sunny following the release of Warren Buffett’s annual shareholder letter over the weekend, and the Oracle of Omaha made positive comments about the sustainability of the current bull market, which was able to overcome early declines in the major market benchmarks. However, some stocks didn’t fare as well as the overall market, and Tesla (NASDAQ:TSLA), AmTrust Financial Services (NASDAQ:AFSI), and Horizon Pharma (NASDAQ:HZNP) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    In trading on Tuesday, financial shares fell 0.32 percent. Meanwhile, top losers in the sector included Oak Valley Bancorp (NASDAQ: OVLY), down 7 percent, and AmTrust Financial Services Inc (NASDAQ: AFSI) down 5 percent.

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Paul Ausick]

    AmTrust Financial Services Inc. (NASDAQ: AFSI) dropped about 28% Tuesday to post a new 52-week low of $13.51 after closing Monday at $18.87. The stock’s 52-week high is $28.48. Volume of about 19 million shares was about 9 times the daily average of around 2.1 million. A whistleblower report has resulted in an SEC probe into the company’s accounting practices.